This Test May Guide AML Therapy for Black Pediatric Patients

A new analysis suggests that a polygenic score can help determine the best drug regimens for young Black patients with AML who often face worse outcomes than White patients.

Related Keywords

United States , American , Cynthiae Dunbar , Jatinder Lamba , American Society Of Hematology , University Of Florida College Pharmacy , National Heart , Blood Institute , Translational Stem Cell Biology Branch , American Society , Florida College , Acute Leukemia , Acute Leukaemia , Genomics Genomic Medicine , Children , Child , Childhood , Ediatrics , Kids , Genetics , Social Determinants Of Health , Doh , Social Determinants Of Health Sdoh , Facial , Health Care Economics , Pharmacogenomics , Personalized Medicine , Personalised Medicine , Leukemia Leukaemia Blood Cancer , Acute Myeloblastic Leukemia , Acute Myeloid Leukemia , Acute Myelocytic Leukemia ,